Véronique Verrièle

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response

Pascal Jézéquel, Delphine Loussouarn, Catherine Guérin‐Charbonnel et al. · Breast Cancer Research · 2015 · 326 citations · Full text

Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer

Frédérique Penault‐Llorca, Fabrice André, Christine Sagan et al. · Journal of Clinical Oncology · 2009 · 238 citations · Full text

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Denis Moro‐Sibilot, Nathalie Cozic, M. Pérol et al. · Annals of Oncology · 2019 · 192 citations · Full text

Medicinal Chemistry, Ros1-positive Nsclc, Medicine +4

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck et al. · Breast Cancer Research · 2019 · 114 citations · Full text

Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database

Vahan Képénékian, D. Élias, Guillaume Passot et al. · European Journal of Cancer · 2016 · 89 citations

Systemic Chemotherapy, Comprehensive Treatment, Surgical Oncology +8